Posts by Justin Gainor, MD
-
Molecular Features Identified That Predict Response to Checkpoint Inhibitors in NSCLC
Justin Gainor, MD, and colleagues have published findings from the first joint analysis of the Stand Up To Cancer–Mark Foundation non-small cell lung cancer cohort, reporting newly identified genomic and transcriptomic biomarkers of response and resistance to anti–PD-1 and anti–PD-L1 immune checkpoint inhibitors.
-
About the Henri and Belinda Termeer Center for Targeted Therapies at Mass General Brigham Cancer Institute
Justin Gainor, MD, discusses the Henri and Belinda Termeer Center for Targeted Therapies at Mass General Brigham Cancer Institute.
Biography
Justin Gainor, MD, is director of the Center for Thoracic Cancers Program and director of Targeted Immunotherapy at Mass General Brigham Cancer Institute and an associate professor of Medicine at Harvard Medical School.
Mass General Brigham Cancer Institute
Mass General Brigham Cancer Institute unites leading experts and resources across our academic medical centers, making it one of the nation’s top providers of cancer care.